Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

351

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Asthma
Interventions
DRUG

Fluticasone furoate 50mcg

Once daily inhalation powder via Novel Dry Powder Inhaler

DRUG

Fluticasone propionate 100mcg

Twice daily inhalation powder via DISKUS/ACCUHALER

DRUG

Placebo

Inhalation powder via Novel Dry Powder Inhaler and DISKUS?ACCUHALER

Trial Locations (42)

13502

GSK Investigational Site, Utica

20814

GSK Investigational Site, Bethesda

29118

GSK Investigational Site, Orangeburg

32811

GSK Investigational Site, Orlando

33016

GSK Investigational Site, Hialeah

33180

GSK Investigational Site, Aventura

33756

GSK Investigational Site, Clearwater

44100

GSK Investigational Site, Guadalajara

45040

GSK Investigational Site, Zapopan

45242

GSK Investigational Site, Cincinnati

65203

GSK Investigational Site, Columbia

70006

GSK Investigational Site, Metairie

70584

GSK Investigational Site, Sunset

75110

GSK Investigational Site, Corsicana

76712

GSK Investigational Site, Waco

79903

GSK Investigational Site, El Paso

89119

GSK Investigational Site, Las Vegas

90025

GSK Investigational Site, Los Angeles

90274

GSK Investigational Site, Rolling Hills Estates

95117

GSK Investigational Site, San Jose

95819

GSK Investigational Site, Sacramento

123182

GSK Investigational Site, Moscow

194356

GSK Investigational Site, Saint Petersburg

630087

GSK Investigational Site, Novosibirsk

650000

GSK Investigational Site, Kemerovo

08724

GSK Investigational Site, Brick

04530

GSK Investigational Site, Mexico City

7609 PP

GSK Investigational Site, Almelo

5623 EJ

GSK Investigational Site, Eindhoven

5644 RX

GSK Investigational Site, Eindhoven

1718 BG

GSK Investigational Site, Hoogwoud

7207 AE

GSK Investigational Site, Zutphen

Lima 1

GSK Investigational Site, Lima

Lima 27

GSK Investigational Site, Lima

Lima 32

GSK Investigational Site, San Miguel

LIMA 29

GSK Investigational Site, Lima

85-046

GSK Investigational Site, Bydgoszcz

31-159

GSK Investigational Site, Krakow

93-329

GSK Investigational Site, Lodz

20-552

GSK Investigational Site, Lublin

60-693

GSK Investigational Site, Poznan

50-088

GSK Investigational Site, Wroclaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01436110 - Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma | Biotech Hunter | Biotech Hunter